[1]
Palanisamy Sivanandy, “Current Trends in the Treatment of Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer”, J. Pharm. Nutr. Sci., vol. 10, no. 4, pp. 155–168, Aug. 2020.